ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Metabolic complications"

  • 2020 American Transplant Congress

    Characterization of Gut Microbiome in Liver Transplant Recipients with Non-Alcoholic Steatohepatitis

    S. Sataphaty1, P. Banerjee2, J. Pierre3, R. Heda3, S. Dutta3, D. D. Higgins4, V. Mas5, S. Khan6, V. Mupparaju3, S. R. Nair7, J. D. Eason8, D. Kleiner9, D. Maluf10

    1Department of Surgery, Division of Hepatology and Sandra Atlas Bass Center for Liver Diseases, Northwell Health, NYC, NY, 2School of Public Health, University of Memphis, Memphis, TN, 3University of Tennessee Health Science Center, Memphis, TN, 4University of Memphis, Memphis, TN, 5James D Eason Transplant Institute, Memphis, TN, 6Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NYC, NY, 7Department of Surgery, James D Eason Transplant Institute, Memphis, TN, 8Department of Surgery, James D Eason Transplant Institute, NYC, TN, 9Laboratory of Pathology/National Cancer Institute, Bethesda, WA, 10Department of Surgery_ University of Tennessee, James D Eason Transplant Institute, NYC, TN

    *Purpose: Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) is a growing problem globally and recurs even after liver transplant (LT).…
  • 2020 American Transplant Congress

    Long Term Outcome of Patients Transplanted for Non Alcoholic Steatohepatitis Related Cirrhosis

    W. Alhamoudi1, I. Salih2, S. Yousif2, M. Shawkat3, K. Bzeizi2, S. Alghamdi2, A. Albenmousa2, D. Broering2

    1Medicine, King Saud University, Riyadh, Saudi Arabia, 2Liver Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia, 3Internal Medicine, Minia University, Minia, Egypt

    *Purpose: Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disease worldwide. Cirrhosis secondary to Nonalcoholic Steatohepatitis (NASH) is projected to…
  • 2020 American Transplant Congress

    Proportion of Veillonella and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation

    K. Ji Eun1, H. Kim1, H. Cho2, J. Park3, J. Lee4, D. Kim1, K. Joo1, Y. Kim1, H. Lee1

    1Seoul National University Hospital, Seoul, Korea, Republic of, 2Chungbuk National University Hospital, Cheongju, Korea, Republic of, 3Kangwon National University Hospital, Chuncheon, Korea, Republic of, 4Seoul National University Boramae Hospital, Seoul, Korea, Republic of

    *Purpose: New-onset diabetes transplantation after transplantation (NODAT) is an important metabolic complication after kidney transplantation, although its mechanism is not yet fully elucidated. Recent studies…
  • 2020 American Transplant Congress

    Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters

    J. Noble, F. Terrec, T. Jouve, H. Neciri Bennani, P. Benhamou, P. Malvezzi, B. Janbon, D. Giovannini, L. Rostaing

    Nephrology and Transplant Unit, CHU Grenoble, Grenoble, France

    *Purpose: Calcineurin inhibitors (CNIs) and steroids are strongly associated with new-onset diabetes after transplantation (NODAT), worsening of pre-existing diabetes, and cardiovascular events. We assessed the…
  • 2020 American Transplant Congress

    The Impact of Increased Visceral Fat in Kidney Transplant Recipients

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

    Ehime University, Toon, Japan

    *Purpose: An increased amount of visceral fat (VF) has been reported as a precursor to metabolic syndrome and is a risk factor for renal dysfunction.…
  • 2019 American Transplant Congress

    New-Onset Diabetes after Kidney Transplantation: Risk Factors and Early Graft Function Outcome

    Z. Li, W. Peng, J. Chen

    Kidney Disease Center, First Affiliated Hospital of Zhejiang University, Hangzhou, China

    *Purpose: New-onset of diabetes mellitus after transplantation (NODAT) is a serious and common complication following solid organ transplantation. Our study aims to examine the risk…
  • 2019 American Transplant Congress

    Comparison of Two Glucagon-Like-Peptide-1 Analogs (GLP -1) Dulaglutide vs Liraglutide for the Management of Diabetes in Solid Organ Transplant (SOT)

    P. Singh, M. Taufeeq, T. E. Pesavento, K. Washburn, D. Walsh, S. Meng

    Ohio State University, Columbus, OH

    *Purpose: Poorly controlled Type-2 diabetes is an important contributor to graft dysfunction, and cardiovascular morbidity in the SOT. GLP-1-analog has been widely used in the…
  • 2019 American Transplant Congress

    Comparison of Simultaneous Pancreas kidney Transplantation to Kidney Transplantation Alone for Type 2 Diabetes with End Stage Renal Disease

    Y. Fu, Z. Shen

    Kidney&Pancreas Transplant, Tianjin First Center Hospital, Tianjin, China

    *Purpose: To compare the clinic outcomes of simultaneous pancreas-kidney transplantation (SPK) with kidney transplantation alone (KTA) in Type 2 Diabetes patients with ESRD.*Methods: 97 type…
  • 2019 American Transplant Congress

    An Immediate and Persistent Post-Reperfusion Metabolic Collapse Precedes Delayed Graft Function (DGF)

    J. Lindeman

    Surgery, Leiden University Medical Center, Leiden, Netherlands

    *Purpose: Delayed graft function (DGF) is the manifestation of ischemia reperfusion injury (IRI) in the context of kidney transplantation. Despite clear preclinical successes, a proven…
  • 2019 American Transplant Congress

    The Use of High Volume Perioperative Normal Saline Increases the Risk of Delayed Graft Function after Kidney Transplantation

    K. Kolodzie1, O. S. Cakmakkaya2, E. S. Boparai3, M. Tavakol4, J. Feiner1, C. U. Niemann5

    1Anesthesia & Perioperative Care, University of California San Francisco, San Francisco, CA, 2Dept. of Medical Education, University Istanbul – Cerrahpasa, Istanbul, Turkey, 3School of Medicine, George Washington University, Washington, DC, 4Dept. of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA, 5Anesthesia & Perioperative Care, and Dept. of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA

    *Purpose: Metabolic and physiologic effects of high volume perioperative Normal Saline (NS) resuscitation are well described, but the impact on delayed graft function (DGF) remains…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 11
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences